HomeCompareCIIHF vs MRK

CIIHF vs MRK: Dividend Comparison 2026

CIIHF yields 2.17% · MRK yields 2.81%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CIIHF wins by $92.02M in total portfolio value· pulled ahead in Year 2
10 years
CIIHF
CIIHF
● Live price
2.17%
Share price
$3.50
Annual div
$0.08
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$92.08M
Annual income
$84,596,087.57
Full CIIHF calculator →
MRK
Merck & Co. Inc.
● Live price
2.81%
Share price
$118.10
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$57.7K
Annual income
$10,113.78
Full MRK calculator →

Portfolio growth — CIIHF vs MRK

📍 CIIHF pulled ahead of the other in Year 2

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCIIHFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CIIHF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CIIHF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CIIHF
Annual income on $10K today (after 15% tax)
$184.66/yr
After 10yr DRIP, annual income (after tax)
$71,906,674.43/yr
MRK
Annual income on $10K today (after 15% tax)
$238.95/yr
After 10yr DRIP, annual income (after tax)
$8,596.71/yr
At 15% tax rate, CIIHF beats the other by $71,898,077.72/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CIIHF + MRK for your $10,000?

CIIHF: 50%MRK: 50%
100% MRK50/50100% CIIHF
Portfolio after 10yr
$46.07M
Annual income
$42,303,100.67/yr
Blended yield
91.83%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

CIIHF
No analyst data
Altman Z
0.7
Piotroski
9/9
MRK
Analyst Ratings
24
Buy
12
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+8.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CIIHF buys
0
MRK buys
8
PoliticianChamberTickerTypeAmountDate
Josh Gottheimer🏢 House$MRK▲ Buy$1,001 - $15,0002026-02-04
Michael McCaul🏢 House$MRK▼ Sell$15,001 - $50,0002026-01-13
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-12-19
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-12-18
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-11-13
Ro Khanna🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-29
Val Hoyle🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-23
Marjorie Taylor Greene🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-28
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-08-14
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-05
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCIIHFMRK
Forward yield2.17%2.81%
Annual dividend / share$0.08$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%32.7%
Portfolio after 10y$92.08M$57.7K
Annual income after 10y$84,596,087.57$10,113.78
Total dividends collected$91.49M$29.8K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: CIIHF vs MRK ($10,000, DRIP)

YearCIIHF PortfolioCIIHF Income/yrMRK PortfolioMRK Income/yrGap
1$11,134$434.49$11,213$373.04$79.00MRK
2← crossover$12,818$904.27$12,667$512.06+$151.00CIIHF
3$15,661$1,945.81$14,439$708.14+$1.2KCIIHF
4$21,201$4,443.73$16,640$988.16+$4.6KCIIHF
5$33,930$11,244.21$19,432$1,394.07+$14.5KCIIHF
6$69,940$33,635.02$23,057$1,992.90+$46.9KCIIHF
7$204,429$129,593.41$27,889$2,894.79+$176.5KCIIHF
8$926,763$708,023.70$34,518$4,286.29+$892.2KCIIHF
9$6,991,208$5,999,572.42$43,912$6,494.35+$6.95MCIIHF
10$92,076,681$84,596,087.57$57,714$10,113.78+$92.02MCIIHF

CIIHF vs MRK: Complete Analysis 2026

CIIHFStock

CITIC Securities Company Limited provides various financial products and services in Mainland China and internationally. It operates through Investment Banking, Brokerage, Trading, Asset Management, and Others segments. The company offers investment banking services, including equity and debt financing, as well as fundraising and financial advisory services to a range of enterprises and other institutional clients. It is also involved in the broking of securities and futures; distribution of financial products; and trading and market-making of equity products, fixed income products and derivatives, foreign exchange, margin financing and securities lending, alternative investment, and commodities business. In addition, the company offers asset management services, such as collective asset management, specialized asset management, separately managed account, fund management, and other investment accounts management; private equity investment and other services; and custody and research services. Further, it provides institutional brokerage, investment advisory and management, investment consultancy, fiduciary management, fund, real estate, business training, and financial products and securities investment services. Additionally, the company offers finance outsourcing, bond issuance, offshore portfolio hedge and investment fund, fund distribution, leveraged foreign exchange and other transactions, investment with self-owned capital, cash transactions, property management and leasing, and other services. It also engages in information technology development, technical consulting, research and development of financial products, portfolio design, and consulting activities. CITIC Securities Company Limited was incorporated in 1995 and is based in Beijing, the People's Republic of China.

Full CIIHF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this CIIHF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CIIHF vs SCHDCIIHF vs JEPICIIHF vs OCIIHF vs KOCIIHF vs MAINCIIHF vs JNJCIIHF vs ABBVCIIHF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.